Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPV in newly diagnosed multiple myeloma
NCT02237261Phase 2Completed
- Sponsor
- Heidelberg University Hospital
- Start
- Nov 2014
- Primary completion
- Oct 2018
- Modality
- Modified Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine, bortezomib, prednisone in multiple myeloma (MM), sponsored by Heidelberg University Hospital. Started Nov 2014; status: completed.
02
Drugs
bendamustinebortezomibprednisone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02237261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237261.